nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—Temozolomide—malignant glioma	0.547	1	CbGbCtD
Budesonide—Hyperadrenocorticism—Temozolomide—malignant glioma	0.0293	0.0649	CcSEcCtD
Budesonide—Cushing's syndrome—Carmustine—malignant glioma	0.0207	0.0457	CcSEcCtD
Budesonide—Clotting—Temozolomide—malignant glioma	0.0127	0.0281	CcSEcCtD
Budesonide—Impaired healing—Carmustine—malignant glioma	0.0109	0.024	CcSEcCtD
Budesonide—Disorder sight—Temozolomide—malignant glioma	0.00952	0.0211	CcSEcCtD
Budesonide—Haemorrhoids—Temozolomide—malignant glioma	0.00771	0.0171	CcSEcCtD
Budesonide—Oral candidiasis—Carmustine—malignant glioma	0.00739	0.0163	CcSEcCtD
Budesonide—Oral candidiasis—Temozolomide—malignant glioma	0.00714	0.0158	CcSEcCtD
Budesonide—Tooth disorder—Temozolomide—malignant glioma	0.00699	0.0155	CcSEcCtD
Budesonide—Abscess—Carmustine—malignant glioma	0.00593	0.0131	CcSEcCtD
Budesonide—Otitis media—Temozolomide—malignant glioma	0.00582	0.0129	CcSEcCtD
Budesonide—Coagulopathy—Temozolomide—malignant glioma	0.00582	0.0129	CcSEcCtD
Budesonide—Endocrine disorder—Temozolomide—malignant glioma	0.00547	0.0121	CcSEcCtD
Budesonide—Viral infection—Temozolomide—malignant glioma	0.00502	0.0111	CcSEcCtD
Budesonide—Leukocytosis—Carmustine—malignant glioma	0.00499	0.0111	CcSEcCtD
Budesonide—Herpes simplex—Temozolomide—malignant glioma	0.00492	0.0109	CcSEcCtD
Budesonide—Neck pain—Carmustine—malignant glioma	0.00475	0.0105	CcSEcCtD
Budesonide—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00454	0.01	CcSEcCtD
Budesonide—Candida infection—Carmustine—malignant glioma	0.00448	0.00992	CcSEcCtD
Budesonide—Candida infection—Temozolomide—malignant glioma	0.00433	0.00958	CcSEcCtD
Budesonide—Abnormal vision—Carmustine—malignant glioma	0.00409	0.00906	CcSEcCtD
Budesonide—Abnormal vision—Temozolomide—malignant glioma	0.00396	0.00875	CcSEcCtD
Budesonide—Swelling—Carmustine—malignant glioma	0.00386	0.00855	CcSEcCtD
Budesonide—Ear pain—Temozolomide—malignant glioma	0.00386	0.00854	CcSEcCtD
Budesonide—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00378	0.00838	CcSEcCtD
Budesonide—Gastroenteritis—Temozolomide—malignant glioma	0.00371	0.00822	CcSEcCtD
Budesonide—Vascular purpura—Temozolomide—malignant glioma	0.00368	0.00814	CcSEcCtD
Budesonide—Amnesia—Carmustine—malignant glioma	0.00363	0.00802	CcSEcCtD
Budesonide—Nasal congestion—Temozolomide—malignant glioma	0.00361	0.008	CcSEcCtD
Budesonide—Amnesia—Temozolomide—malignant glioma	0.0035	0.00775	CcSEcCtD
Budesonide—Thirst—Temozolomide—malignant glioma	0.00346	0.00766	CcSEcCtD
Budesonide—Purpura—Temozolomide—malignant glioma	0.00342	0.00756	CcSEcCtD
Budesonide—Face oedema—Carmustine—malignant glioma	0.00329	0.00728	CcSEcCtD
Budesonide—Affect lability—Temozolomide—malignant glioma	0.00324	0.00717	CcSEcCtD
Budesonide—Face oedema—Temozolomide—malignant glioma	0.00318	0.00703	CcSEcCtD
Budesonide—Mood swings—Temozolomide—malignant glioma	0.00312	0.0069	CcSEcCtD
Budesonide—Hypokalaemia—Carmustine—malignant glioma	0.0031	0.00686	CcSEcCtD
Budesonide—Hypokalaemia—Temozolomide—malignant glioma	0.003	0.00663	CcSEcCtD
Budesonide—Breast disorder—Temozolomide—malignant glioma	0.00297	0.00658	CcSEcCtD
Budesonide—Abdominal distension—Temozolomide—malignant glioma	0.00286	0.00634	CcSEcCtD
Budesonide—Sweating increased—Temozolomide—malignant glioma	0.00277	0.00613	CcSEcCtD
Budesonide—Bronchitis—Temozolomide—malignant glioma	0.00274	0.00606	CcSEcCtD
Budesonide—Dysuria—Temozolomide—malignant glioma	0.00266	0.00589	CcSEcCtD
Budesonide—Pollakiuria—Temozolomide—malignant glioma	0.00263	0.00582	CcSEcCtD
Budesonide—Weight increased—Temozolomide—malignant glioma	0.00259	0.00573	CcSEcCtD
Budesonide—Urinary tract infection—Carmustine—malignant glioma	0.00255	0.00565	CcSEcCtD
Budesonide—Infestation NOS—Temozolomide—malignant glioma	0.00254	0.00561	CcSEcCtD
Budesonide—Infestation—Temozolomide—malignant glioma	0.00254	0.00561	CcSEcCtD
Budesonide—Urinary tract infection—Temozolomide—malignant glioma	0.00247	0.00546	CcSEcCtD
Budesonide—Sinusitis—Temozolomide—malignant glioma	0.00238	0.00527	CcSEcCtD
Budesonide—Haemoglobin—Carmustine—malignant glioma	0.00237	0.00524	CcSEcCtD
Budesonide—Haemorrhage—Carmustine—malignant glioma	0.00236	0.00522	CcSEcCtD
Budesonide—Oedema peripheral—Carmustine—malignant glioma	0.00232	0.00514	CcSEcCtD
Budesonide—Connective tissue disorder—Carmustine—malignant glioma	0.00232	0.00513	CcSEcCtD
Budesonide—Haemoglobin—Temozolomide—malignant glioma	0.00229	0.00507	CcSEcCtD
Budesonide—Haemorrhage—Temozolomide—malignant glioma	0.00228	0.00504	CcSEcCtD
Budesonide—Visual impairment—Carmustine—malignant glioma	0.00227	0.00503	CcSEcCtD
Budesonide—Pharyngitis—Temozolomide—malignant glioma	0.00226	0.005	CcSEcCtD
Budesonide—Urinary tract disorder—Temozolomide—malignant glioma	0.00225	0.00498	CcSEcCtD
Budesonide—Oedema peripheral—Temozolomide—malignant glioma	0.00224	0.00497	CcSEcCtD
Budesonide—Connective tissue disorder—Temozolomide—malignant glioma	0.00224	0.00495	CcSEcCtD
Budesonide—Urethral disorder—Temozolomide—malignant glioma	0.00223	0.00494	CcSEcCtD
Budesonide—Eye disorder—Carmustine—malignant glioma	0.0022	0.00487	CcSEcCtD
Budesonide—Visual impairment—Temozolomide—malignant glioma	0.00219	0.00486	CcSEcCtD
Budesonide—Flushing—Carmustine—malignant glioma	0.00219	0.00484	CcSEcCtD
Budesonide—Eye disorder—Temozolomide—malignant glioma	0.00213	0.00471	CcSEcCtD
Budesonide—Flushing—Temozolomide—malignant glioma	0.00211	0.00468	CcSEcCtD
Budesonide—Cardiac disorder—Temozolomide—malignant glioma	0.00211	0.00468	CcSEcCtD
Budesonide—Alopecia—Carmustine—malignant glioma	0.00208	0.00461	CcSEcCtD
Budesonide—Angiopathy—Temozolomide—malignant glioma	0.00207	0.00457	CcSEcCtD
Budesonide—Mental disorder—Carmustine—malignant glioma	0.00206	0.00457	CcSEcCtD
Budesonide—Immune system disorder—Temozolomide—malignant glioma	0.00206	0.00455	CcSEcCtD
Budesonide—Mediastinal disorder—Temozolomide—malignant glioma	0.00205	0.00454	CcSEcCtD
Budesonide—Malnutrition—Carmustine—malignant glioma	0.00205	0.00454	CcSEcCtD
Budesonide—Alopecia—Temozolomide—malignant glioma	0.00201	0.00445	CcSEcCtD
Budesonide—Mental disorder—Temozolomide—malignant glioma	0.002	0.00442	CcSEcCtD
Budesonide—Back pain—Carmustine—malignant glioma	0.00198	0.00439	CcSEcCtD
Budesonide—Malnutrition—Temozolomide—malignant glioma	0.00198	0.00439	CcSEcCtD
Budesonide—Dysgeusia—Temozolomide—malignant glioma	0.00194	0.0043	CcSEcCtD
Budesonide—Vision blurred—Carmustine—malignant glioma	0.00193	0.00428	CcSEcCtD
Budesonide—Tremor—Carmustine—malignant glioma	0.00192	0.00425	CcSEcCtD
Budesonide—Back pain—Temozolomide—malignant glioma	0.00192	0.00424	CcSEcCtD
Budesonide—Anaemia—Carmustine—malignant glioma	0.0019	0.0042	CcSEcCtD
Budesonide—Agitation—Carmustine—malignant glioma	0.00189	0.00417	CcSEcCtD
Budesonide—Vision blurred—Temozolomide—malignant glioma	0.00187	0.00414	CcSEcCtD
Budesonide—Tremor—Temozolomide—malignant glioma	0.00186	0.00411	CcSEcCtD
Budesonide—Ill-defined disorder—Temozolomide—malignant glioma	0.00184	0.00407	CcSEcCtD
Budesonide—Anaemia—Temozolomide—malignant glioma	0.00183	0.00406	CcSEcCtD
Budesonide—Agitation—Temozolomide—malignant glioma	0.00182	0.00403	CcSEcCtD
Budesonide—Angioedema—Temozolomide—malignant glioma	0.00181	0.00401	CcSEcCtD
Budesonide—Malaise—Temozolomide—malignant glioma	0.00179	0.00396	CcSEcCtD
Budesonide—Vertigo—Temozolomide—malignant glioma	0.00178	0.00394	CcSEcCtD
Budesonide—Hypertension—Carmustine—malignant glioma	0.00177	0.00392	CcSEcCtD
Budesonide—Palpitations—Temozolomide—malignant glioma	0.00175	0.00388	CcSEcCtD
Budesonide—Chest pain—Carmustine—malignant glioma	0.00175	0.00387	CcSEcCtD
Budesonide—Myalgia—Carmustine—malignant glioma	0.00175	0.00387	CcSEcCtD
Budesonide—Anxiety—Carmustine—malignant glioma	0.00174	0.00385	CcSEcCtD
Budesonide—Cough—Temozolomide—malignant glioma	0.00173	0.00383	CcSEcCtD
Budesonide—Hypertension—Temozolomide—malignant glioma	0.00171	0.00379	CcSEcCtD
Budesonide—Confusional state—Carmustine—malignant glioma	0.00169	0.00374	CcSEcCtD
Budesonide—Arthralgia—Temozolomide—malignant glioma	0.00169	0.00374	CcSEcCtD
Budesonide—Myalgia—Temozolomide—malignant glioma	0.00169	0.00374	CcSEcCtD
Budesonide—Anxiety—Temozolomide—malignant glioma	0.00168	0.00372	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00168	0.00371	CcSEcCtD
Budesonide—Discomfort—Temozolomide—malignant glioma	0.00167	0.00369	CcSEcCtD
Budesonide—Infection—Carmustine—malignant glioma	0.00166	0.00368	CcSEcCtD
Budesonide—Dry mouth—Temozolomide—malignant glioma	0.00165	0.00365	CcSEcCtD
Budesonide—Tachycardia—Carmustine—malignant glioma	0.00163	0.00362	CcSEcCtD
Budesonide—Confusional state—Temozolomide—malignant glioma	0.00163	0.00361	CcSEcCtD
Budesonide—Anaphylactic shock—Temozolomide—malignant glioma	0.00162	0.00358	CcSEcCtD
Budesonide—Infection—Temozolomide—malignant glioma	0.00161	0.00356	CcSEcCtD
Budesonide—Anorexia—Carmustine—malignant glioma	0.0016	0.00353	CcSEcCtD
Budesonide—Nervous system disorder—Temozolomide—malignant glioma	0.00159	0.00351	CcSEcCtD
Budesonide—Skin disorder—Temozolomide—malignant glioma	0.00157	0.00348	CcSEcCtD
Budesonide—Hyperhidrosis—Temozolomide—malignant glioma	0.00156	0.00346	CcSEcCtD
Budesonide—Anorexia—Temozolomide—malignant glioma	0.00154	0.00341	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00153	0.00338	CcSEcCtD
Budesonide—Insomnia—Carmustine—malignant glioma	0.00151	0.00335	CcSEcCtD
Budesonide—Paraesthesia—Carmustine—malignant glioma	0.0015	0.00333	CcSEcCtD
Budesonide—Dyspnoea—Carmustine—malignant glioma	0.00149	0.0033	CcSEcCtD
Budesonide—Somnolence—Carmustine—malignant glioma	0.00149	0.00329	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00147	0.00326	CcSEcCtD
Budesonide—Insomnia—Temozolomide—malignant glioma	0.00146	0.00324	CcSEcCtD
Budesonide—Decreased appetite—Carmustine—malignant glioma	0.00146	0.00322	CcSEcCtD
Budesonide—Paraesthesia—Temozolomide—malignant glioma	0.00145	0.00322	CcSEcCtD
Budesonide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00145	0.0032	CcSEcCtD
Budesonide—Dyspnoea—Temozolomide—malignant glioma	0.00144	0.00319	CcSEcCtD
Budesonide—Somnolence—Temozolomide—malignant glioma	0.00144	0.00318	CcSEcCtD
Budesonide—Pain—Carmustine—malignant glioma	0.00143	0.00317	CcSEcCtD
Budesonide—Constipation—Carmustine—malignant glioma	0.00143	0.00317	CcSEcCtD
Budesonide—Dyspepsia—Temozolomide—malignant glioma	0.00142	0.00315	CcSEcCtD
Budesonide—Decreased appetite—Temozolomide—malignant glioma	0.00141	0.00311	CcSEcCtD
Budesonide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0014	0.00309	CcSEcCtD
Budesonide—Fatigue—Temozolomide—malignant glioma	0.00139	0.00309	CcSEcCtD
Budesonide—Constipation—Temozolomide—malignant glioma	0.00138	0.00306	CcSEcCtD
Budesonide—Pain—Temozolomide—malignant glioma	0.00138	0.00306	CcSEcCtD
Budesonide—Feeling abnormal—Carmustine—malignant glioma	0.00138	0.00305	CcSEcCtD
Budesonide—Gastrointestinal pain—Carmustine—malignant glioma	0.00137	0.00303	CcSEcCtD
Budesonide—Feeling abnormal—Temozolomide—malignant glioma	0.00133	0.00295	CcSEcCtD
Budesonide—Abdominal pain—Carmustine—malignant glioma	0.00132	0.00293	CcSEcCtD
Budesonide—Body temperature increased—Carmustine—malignant glioma	0.00132	0.00293	CcSEcCtD
Budesonide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00132	0.00293	CcSEcCtD
Budesonide—Urticaria—Temozolomide—malignant glioma	0.00129	0.00284	CcSEcCtD
Budesonide—Abdominal pain—Temozolomide—malignant glioma	0.00128	0.00283	CcSEcCtD
Budesonide—Body temperature increased—Temozolomide—malignant glioma	0.00128	0.00283	CcSEcCtD
Budesonide—Hypersensitivity—Carmustine—malignant glioma	0.00123	0.00273	CcSEcCtD
Budesonide—Asthenia—Carmustine—malignant glioma	0.0012	0.00266	CcSEcCtD
Budesonide—Hypersensitivity—Temozolomide—malignant glioma	0.00119	0.00264	CcSEcCtD
Budesonide—Asthenia—Temozolomide—malignant glioma	0.00116	0.00257	CcSEcCtD
Budesonide—Diarrhoea—Carmustine—malignant glioma	0.00115	0.00254	CcSEcCtD
Budesonide—Pruritus—Temozolomide—malignant glioma	0.00114	0.00253	CcSEcCtD
Budesonide—Dizziness—Carmustine—malignant glioma	0.00111	0.00245	CcSEcCtD
Budesonide—Diarrhoea—Temozolomide—malignant glioma	0.00111	0.00245	CcSEcCtD
Budesonide—Dizziness—Temozolomide—malignant glioma	0.00107	0.00237	CcSEcCtD
Budesonide—Vomiting—Carmustine—malignant glioma	0.00106	0.00236	CcSEcCtD
Budesonide—Rash—Carmustine—malignant glioma	0.00106	0.00234	CcSEcCtD
Budesonide—Dermatitis—Carmustine—malignant glioma	0.00105	0.00233	CcSEcCtD
Budesonide—Headache—Carmustine—malignant glioma	0.00105	0.00232	CcSEcCtD
Budesonide—Vomiting—Temozolomide—malignant glioma	0.00103	0.00228	CcSEcCtD
Budesonide—Rash—Temozolomide—malignant glioma	0.00102	0.00226	CcSEcCtD
Budesonide—Dermatitis—Temozolomide—malignant glioma	0.00102	0.00226	CcSEcCtD
Budesonide—Headache—Temozolomide—malignant glioma	0.00101	0.00224	CcSEcCtD
Budesonide—Nausea—Carmustine—malignant glioma	0.000994	0.0022	CcSEcCtD
Budesonide—Nausea—Temozolomide—malignant glioma	0.000961	0.00213	CcSEcCtD
Budesonide—Triamcinolone—BCHE—malignant glioma	0.00058	0.379	CrCbGaD
Budesonide—Dexamethasone—CYP2B6—malignant glioma	0.000339	0.221	CrCbGaD
Budesonide—Triamcinolone—PTGS2—malignant glioma	0.000267	0.174	CrCbGaD
Budesonide—Betamethasone—PTGS2—malignant glioma	0.000219	0.143	CrCbGaD
Budesonide—Dexamethasone—PTGS2—malignant glioma	0.000127	0.0831	CrCbGaD
